A new UICC report shows how countries translate cancer plans into real‑world impact, highlighting the governance, financing, and partnerships needed to implement national cancer control plans effectively.
What makes national cancer plans work in practice...
On the occasion of IARC’s 60th anniversary, Director Dr Elisabete Weiderpass speaks about how independent research on cancer risk, data and prevention can better inform policy, and how to ensure that evidence is consistently translated into action.
The impact of six decades of cancer research: an...
The Access to Oncology Medicines (ATOM) Coalition partner Cepheid has made its first mRNA precision diagnostics for chronic myeloid leukaemia (CML) monitoring available to low- and lower-middle-income countries (LLMICs).
This policy aims to support UICC’s commitment to integrity, transparency, and accountability by preventing, detecting, and responding to fraud and corruption across all operations, partnerships, and governance structures.